iBio, Inc.
IBIONASDAQHealthcare● Active
$1.73
$-0.09(-4.95%)
Market Cap$27315788
P/E Ratio—
52W High$3.82
52W Low$0.56
iBio, Inc. (IBIO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IBIO · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.40M | $0.23M | $0.00M | $1.88M | $2.37M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $3.79M | $1.46M |
| Gross Profit | $0.40M | $0.23M | $0.00M | ($1.91M) | $0.91M |
| Gross Margin %(computed) | 100.00% | 100.00% | — | -101.22% | 38.34% |
| Operating Expenses | |||||
| R&D Expenses | $8.31M | $5.18M | $10.33M | $9.83M | $9.99M |
| G&A Expenses | $10.69M | $11.67M | $19.02M | $0.00M | $21.70M |
| Total Operating Expenses | $19.00M | $16.86M | $29.34M | $27.79M | $32.02M |
| Operating Income | ($18.60M) | ($16.63M) | ($29.34M) | ($29.70M) | ($31.11M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.44M | $0.36M | $0.13M | $0.18M | $0.14M |
| Interest Expense | $0.21M | $0.17M | $0.00M | $0.00M | $2.45M |
| Income Before Tax | ($18.38M) | ($15.44M) | ($29.31M) | ($29.51M) | ($23.21M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($18.38M) | ($24.91M) | ($65.01M) | ($50.39M) | ($23.21M) |
| Net Margin %(computed) | — | — | — | — | -978.79% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.75 | $-6.50 | $-106.18 | $-2889.06 | $-59.98 |
| Wtd Avg Shares | 10.50M | 3.83M | 0.61M | 0.02M | 0.39M |
| EBITDA | ($17.04M) | ($14.02M) | ($27.85M) | ($25.72M) | ($28.55M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more iBio, Inc. data
About iBio, Inc. (IBIO) Income Statement
iBio, Inc. (IBIO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, IBIO reported revenue of $0.00B, gross profit of $0.00B (gross margin 100.00%), and net income of ($0.02B) — a net profit margin of -4594.25%.
Frequently asked questions
IBIO · 4 questionsiBio, Inc. (IBIO) reported revenue of $0.00B for 2025, up 77.8% year-over-year.
IBIO revenueIBIO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09